Evidence map›Paper›PMID 40722026›Full record

ArticleBMC biology2025

Targeting the complement-mTOR-autophagy axis: the role of apolipoprotein E in depression.

Yong Li, Chengyuan Xu, Jing Liu, Mengru Guo, Jia Wang, Xianbing Bai, Yujie Cheng, Xinyue Luan, Huailong Pei, Chenlei Zhang and 3 more

Abstract read
In one paragraph

Article in BMC biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yong Li *Department of Rehabilitation Medicine, Center for Rehabilitation Medicine, Rehabilitation & Sports Medicine Research Institute of Zhejiang Province, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, 310014, Zhejiang, China.
Chengyuan Xu *Department of Rehabilitation Medicine, Center for Rehabilitation Medicine, Rehabilitation & Sports Medicine Research Institute of Zhejiang Province, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, 310014, Zhejiang, China.
Jing Liu *Department of Pharmacology, School of Pharmaceutical Sciences, Anhui Medical University, Hefei, 230032, China.
Mengru GuoDepartment of Pharmacology, School of Pharmaceutical Sciences, Anhui Medical University, Hefei, 230032, China.
Jia WangDepartment of Pharmacology, School of Pharmaceutical Sciences, Anhui Medical University, Hefei, 230032, China.
Xianbing BaiDepartment of Pharmacology, School of Pharmaceutical Sciences, Anhui Medical University, Hefei, 230032, China.
Yujie ChengDepartment of Pharmacology, School of Pharmaceutical Sciences, Anhui Medical University, Hefei, 230032, China.
Xinyue LuanDepartment of Pharmacology, School of Pharmaceutical Sciences, Anhui Medical University, Hefei, 230032, China.
Huailong PeiDepartment of Pharmacology, School of Pharmaceutical Sciences, Anhui Medical University, Hefei, 230032, China.
Chenlei ZhangDepartment of Rehabilitation Medicine, Center for Rehabilitation Medicine, Rehabilitation & Sports Medicine Research Institute of Zhejiang Province, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, 310014, Zhejiang, China.
Huan LiuDepartment of Pharmacology, School of Pharmaceutical Sciences, Anhui Medical University, Hefei, 230032, China.
Ming ChenDepartment of Pharmacology, School of Pharmaceutical Sciences, Anhui Medical University, Hefei, 230032, China. chenming@ahmu.edu.cn.
Binliang TangDepartment of Rehabilitation Medicine, Center for Rehabilitation Medicine, Rehabilitation & Sports Medicine Research Institute of Zhejiang Province, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, 310014, Zhejiang, China. cs-binliang.tang@ntu.edu.sg.

Funding

Medical Science and Technology Project of Zhejiang Province 2025KY657National Natural Science Foundation of China No. 82371541Zhejiang Provincial Natural Science Foundation of China ZCLQ24H1702
6 · The paper itself

Abstract

backgroundDepression is a highly prevalent and debilitating psychiatric disorder, and while Apolipoprotein E (ApoE), a critical regulator of lipid transport and neuronal function, has been implicated in regulating depressive behaviors, the underlying mechanisms remain insufficiently understood.

resultsIn this study, we explored the role of ApoE in depression using complementary animal models. We observed significantly reduced ApoE levels in the hippocampus of both chronic social defeat stress (CSDS) and lipopolysaccharide (LPS)-induced depression models, with ApoE knockout (ApoE

conclusionsThese findings demonstrate that ApoE regulates depressive behaviors by modulating the complement-mTOR-autophagy axis, identifying multiple potential therapeutic targets for clinical intervention in depression.

Indexed as

Apolipoproteins EAutophagyComplement C3DepressionTOR Serine-Threonine KinasesAnimalsDisease Models, AnimalHippocampusMaleMiceMice, Inbred C57BLMice, KnockoutSignal TransductionApolipoproteins EComplement C3mTOR protein, mouseTOR Serine-Threonine KinasesApoEAutophagyC3DepressionmTORNeuroinflammation

Identifiers

PMID40722026
PMCPMC12306099

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.